Sanofi and GlaxoSmithKline are working together on a vaccine that they hope to get approved in the first half of next year. Bloomberg
Sanofi and GlaxoSmithKline are working together on a vaccine that they hope to get approved in the first half of next year. Bloomberg

Pandemic-induced demand creates fifth billionaire from Malaysia's rubber glove industry